Yantai, Shandong Province-based Chinese drug-maker Luye Pharma Group has completed a Hong Kong IPO, raising a total of US$764 million by selling 999.6 million shares at HK$5.92 per share, according to an official announcement. The final IPO size is largely inline with previous estimates when the company was reported to plan for a US$750 million […]
Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.
Visit the original source and full text: China Money Network
Any news and links syndicated from other sources are copyright those respective websites and/or publications. We post brief synopsis and links per what the respective websites' RSS feeds provide.